A new collaboration aims to the urgent fight against antimicrobial resistant bacteria. Lyon-headquartered biotech Nosopharm has teamed up with German drug discovery company Evotec…
FIND signs US$14.5 million grant with Unitaid to evaluate next-generation sequencing for rapid, affordable diagnosis of drug-resistant tuberculosis in resource-limited settings. The Foundation for…
GARDP has calls up the global community to develop five new treatments that break antimicrobial resistance (AMR) by 2025. Non profit organsiation GARDP (Global…